Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr4.35 SEK
Change Today +0.16 / 3.82%
Volume 5.7K
SEZI On Other Exchanges
As of 4:43 AM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

senzime ab (SEZI) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/27/14 - kr8.00
52 Week Low
10/21/15 - kr3.55
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SENZIME AB (SEZI)

Related News

No related news articles were found.

senzime ab (SEZI) Related Businessweek News

No Related Businessweek News Found

senzime ab (SEZI) Details

Senzime AB, a biotechnological company, engages in the development and marketing of enzyme based biosensor technology products in Sweden. Its technology is used in the applications of medical and biochemical processes, industries, and other areas. The company offers BioSenz, a product platform that optimizes bioprocesses by continuous measurements of the glucose or lactate concentration in the bioreactor where the measured value can be used for control of the process. It also provides BioSenz auxiliaries, such as SFP1, a special filter unit that collects samples from cultures or fermentations; MP4, a multiplexer unit for monitoring various bioreactors; ACOD, an analog output unit that is mounted on the back of BioSenz for reducing bench space; and other accessories comprising calibration and buffer solutions. Senzime AB was founded in 1997 and is headquartered in Uppsala, Sweden.

Founded in 1997

senzime ab (SEZI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

senzime ab (SEZI) Key Developments

Senzime AB Announces Executive Changes

On 20 November 2015, Senzime announced that the company's advisory board includes two new members with complementary experiences of entrepreneurship, diagnostics and surgery. Furthermore, Anders Jacobson is appointed new CTO (Chief Technical Officer); his background is instrument development for which he was responsible at Biotage AB. Faced with the continued development and strategy issues relating to product and business development as well as commercialization Senzime has expanded its advisory board to include, in addition to Lars Wiklund, Ann-Kristin Berggren, surgical nurse and Tomas Lorant, transplant surgeon. Ann-Kristin Berggren is a registered operating room nurse with experience in the pharmaceutical industry and entrepreneurship. She also has a diploma in Business Administration and now works as an advisor to life-sciences companies. Tomas Lorant is an associate professor in experimental transplant surgery and transplant physician at Uppsala University Hospital. His research concerns transplantation immunology, rejection mechanisms and organ preservation. The research involves both clinical and experimental studies. These new members and their complementary experience in entrepreneurship, diagnostics and surgery will be highly valuable in a number of important areas for the continued development of Senzime. Furthermore, Anders Jacobson is assigned as new CTO. He succeeds Thomas Carlsson, who will retire this spring.

Senzime AB to Report Q1, 2015 Results on May 19, 2015

Senzime AB announced that they will report Q1, 2015 results on May 19, 2015

Senzime AB to Report Q3, 2015 Results on Nov 24, 2015

Senzime AB announced that they will report Q3, 2015 results on Nov 24, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SEZI:SS kr4.35 SEK +0.16

SEZI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SEZI.
View Industry Companies

Industry Analysis


Industry Average

Valuation SEZI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 410.9x
Price/Book 1.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 299.0x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SENZIME AB, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at